We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+14.21%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$987M
AUM Growth
+$120M
Cap. Flow
+$63.5M
Cap. Flow %
6.44%
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.71M
2
DXCM icon
DexCom
DXCM
+$6.59M
3
X
US Steel
X
+$6.1M
4
CMBT
CMB.TECH NV
CMBT
+$5.09M
5
SPLK
Splunk Inc
SPLK
+$4.85M

Top Sells

Rank Stock Value
1
GOOS
Canada Goose Holdings
GOOS
+$21.9M
2
STZ icon
Constellation Brands
STZ
+$9.52M
3
LUMN icon
Lumen
LUMN
+$7.13M
4
WY icon
Weyerhaeuser
WY
+$6.3M
5
FDX icon
FedEx
FDX
+$6.07M

Sector Composition

Rank Sector Weight
1 Healthcare 16.75%
2 Technology 15.19%
3 Consumer Discretionary 13.45%
4 Industrials 12.06%
5 Financials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEEV icon
51
Veeva Systems
VEEV
$33.5B
$2.23M 0.23%
+17,574
New +$1.98M
LNG icon
52
Cheniere Energy
LNG
$54.1B
$2.2M 0.22%
32,146
+23,401
+268% +$1.54M
EL icon
53
Estee Lauder
EL
$30.6B
$2.15M 0.22%
13,010
+3,886
+43% +$571K
S
54
DELISTED
Sprint Corporation
S
$2.15M 0.22%
+379,827
New +$2.35M
ALSN icon
55
Allison Transmission
ALSN
$9.65B
$2.13M 0.22%
+47,522
New +$2.26M
PRAH
56
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.12M 0.21%
19,232
+1,912
+11% +$200K
NOV icon
57
NOV
NOV
$6.94B
$2.1M 0.21%
+78,930
New +$2.24M
MYGN icon
58
Myriad Genetics
MYGN
$289M
$2.07M 0.21%
62,224
+10,999
+21% +$335K
GRUB
59
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$2.06M 0.21%
+14,790
New +$2.29M
FTNT icon
60
Fortinet
FTNT
$120B
$2.04M 0.21%
121,685
+13,815
+13% +$220K
XLNX
61
DELISTED
Xilinx Inc
XLNX
$2.04M 0.21%
16,119
+10,640
+194% +$1.2M
HSII
62
DELISTED
Heidrick & Struggles
HSII
$2.04M 0.21%
53,301
+13,567
+34% +$489K
LW icon
63
Lamb Weston
LW
$7.29B
$2.02M 0.2%
26,916
+21,625
+409% +$1.53M
BMY icon
64
Bristol-Myers Squibb
BMY
$134B
$1.98M 0.2%
41,471
+21,385
+106% +$1.07M
FIX icon
65
Comfort Systems
FIX
$62.3B
$1.97M 0.2%
37,618
+21,636
+135% +$1.08M
HAL icon
66
Halliburton
HAL
$26.6B
$1.96M 0.2%
+67,003
New +$2.02M
BPOP icon
67
Popular Inc
BPOP
$11.1B
$1.95M 0.2%
37,323
+20,790
+126% +$1.1M
IQV icon
68
IQVIA
IQV
$38.4B
$1.94M 0.2%
13,489
+4,289
+47% +$572K
ZIXI
69
DELISTED
Zix Corporation
ZIXI
$1.93M 0.2%
281,150
+8,928
+3% +$63.9K
MNST icon
70
Monster Beverage
MNST
$91.5B
$1.93M 0.2%
70,828
-68,178
-49% -$1.94M
UTHR icon
71
United Therapeutics
UTHR
$21.9B
$1.93M 0.2%
16,401
+5,543
+51% +$646K
UGI icon
72
UGI
UGI
$7.78B
$1.92M 0.19%
34,658
+26,396
+319% +$1.44M
EXPD icon
73
Expeditors International
EXPD
$22.3B
$1.92M 0.19%
+25,250
New +$1.82M
TFC icon
74
Truist Financial
TFC
$63.4B
$1.9M 0.19%
40,869
+24,124
+144% +$1.18M
TSS
75
DELISTED
Total System Services, Inc.
TSS
$1.89M 0.19%
19,897
+16,543
+493% +$1.5M
1 2
3
4 5

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q1 2019 Portfolio in Review

As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.

  • GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
  • GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
  • GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
  • GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
  • GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
  • GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.

Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.